Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase fak'

Search results for: 'research area tyrosine kinase fak'

Items 591-600 of 779

Page
per page
  1. [Ala92]-p16 (84-103)
    B5220 [Ala92]-p16 (84-103)
    Summary: inhibitor of cyclin-dependent kinase-4 (cdk4)/cyclin D1
      Soluble to 2 mg/mL
  2. PP 3
    B7190 PP 3
    Summary: Negative control for the Src kinase inhibitor PP 2
      Soluble in DMSO
  3. AZD8055
    A8214 AZD8055
     2 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥23.3 mg/mL
  4. WP1066
    A4140 WP1066
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL
  5. NQDI 1
    A4474 NQDI 1
    Summary: ASK1, MAP3K5 inhibitor
      soluble in DMSO
  6. Calcineurin Autoinhibitory Peptide
    A4532 Calcineurin Autoinhibitory Peptide
    Summary: CaMKII inhibitor
      Soluble to 1 mg/mL
  7. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  8. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL
  9. AZ20
    A3210 AZ20
     1 Citation
    Target: ATM/ATR
    Summary: ATR inhibitor,potent and selective
      ≥20.65 mg/mL
  10. GSK429286A
    A5611 GSK429286A
    Target: ROCK
    Summary: Selective ROCK1/ROCK2 inhibitor
      ≥21.6 mg/mL

Items 591-600 of 779

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways 657item
  2. Natural Products 6item
  3. Protein 12item
  4. Kits 7item
  5. Screening Library 32item
  6. Peptides 2item
  7. Probes & Dyes 1 item
  8. Cell Biology 4item
  9. Peptides & Proteins 51item
  10. Protein & Immunology 7item
  11. Lab Reagents 1 item
Specificity
  1. Selective 245item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 24item
  2. Irreversible 8item
Target
  1. Cyclin-Dependent Kinases 27item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 16item
  5. Raf 10item
  6. Aurora Kinases 21item
  7. CSF-1R 4item
  8. mTOR 8item
  9. FLT3 13item
  10. GSK-3 9item
  11. PLK 6item
  12. Chk 5item
  13. Eph Receptors 3item
  14. VEGFR 30item
  15. PDGFR 22item
  16. c-Kit 12item
  17. RET 4item
  18. IRAK 3item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 6item
  21. PKB 1 item
  22. JNK 2item
  23. SGK 2item
  24. Bcr-Abl 13item
  25. MEK 4item
  26. FGFR 12item
  27. Pim 4item
  28. Voltage-gated Sodium (NaV) Channels 1 item
  29. Ribosomal s6 kinases (RSK) 1 item
  30. MET 5item
  31. Src 17item
  32. Trk Receptors 3item
  33. STAT 3item
  34. EGFR 19item
  35. ROCK 7item
  36. BTK 1 item
  37. PAK 3item
  38. FAK 7item
  39. BMP and Other Activin Receptors 2item
  40. JAK 16item
  41. Syk 5item
  42. DNA-PK 5item
  43. AMPK 2item
  44. PDHK 1 item
  45. Cytochrome P450 (CYP450) 1 item
  46. ErbB 4item
  47. S6 kinases 1 item
  48. Adenosine Kinases 2item
  49. ERK 4item
  50. Kinases 1 item
  51. c-MET 5item
  52. PKC 12item
  53. Ubiquitin-specific proteases 1 item
  54. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  55. Lyn 2item
  56. HER2 2item
  57. Pyk2 3item
  58. LRRK2 5item
  59. Insulin and Insulin-like Receptors 3item
  60. ALK 7item
  61. ROS1 1 item
  62. Sphingosine kinases (SphKs) 2item
  63. PKG 2item
  64. PKA 5item
  65. Myosin light chain kinases (MLCKs) 2item
  66. CaM-KK 1 item
  67. MELK 1 item
  68. Insulin-like growth factors (IGFs) 1 item
  69. Clk 1 item
  70. NUAK1 1 item
  71. NUAK2 1 item
  72. MK2 2item
  73. Fatty-acid-binding proteins (FABPs) 1 item
  74. Angiotensin-Converting Enzymes (ACEs) 1 item
  75. Tie-2 2item
  76. RSK 2item
  77. phosphatases 1 item
  78. ATM/ATR 4item
  79. CK1 1 item
  80. Farnesyl Diphosphate Synthases 1 item
  81. CK2 3item
  82. HIPK2 1 item
  83. HIPK3 1 item
  84. P2X Receptors 1 item
  85. c-Fyn 1 item
  86. TAK1 1 item
  87. Histamine H1 Receptors 1 item
  88. P110 1 item
  89. Hck 2item
  90. MNK 1 item
  91. 5-Lipoxygenases 1 item
  92. Insulin Receptors 1 item
  93. IRG-1R 1 item
  94. Cdc2-like kinase (Clk) 1 item
  95. eEF-2 1 item
  96. Cdc7 1 item
  97. ZAP-70 1 item
  98. c-RET 3item
  99. p70 rsk 2item
  100. VEGFR3/FLT4 1 item
  101. NTRK1/TRKA 1 item
  102. CSF-1R/c-Fms 1 item
  103. TAM kinase 1 item
  104. KDR 1 item
  105. Fyn kinase 1 item
  106. Abl kinases 1 item
  107. AXL 1 item
  108. c-Fms tyrosine kinase 1 item
  109. insulin 1 item
  110. haspin kinase 1 item
  111. STK 1 item
  112. MSK 1 item
  113. Lyn kinase 1 item
  114. Mer tyrosine kinase 1 item
  115. ErbB-2 1 item
  116. PDK-1 1 item
  117. Histone Acetyltransferases (HATs) 1 item
  118. Prk 1 item
  119. ITK 1 item
  120. NUAK 1 item
  121. DCLK2 1 item
  122. PTK 1 item
  123. phosphatidylinositol kinase 1 item
  124. Lck 1 item
  125. Flk1 2item
  126. Protein Tyrosine Phosphatases 1 item
  127. alkaline phosphatases 1 item
  128. ATPases 1 item
  129. glutamate release 1 item
  130. FGR 1 item
  131. YES 2item
  132. Fyn 2item
  133. ARG 1 item
  134. TRPC channel 1 item
  135. PKD 1 item
  136. Pyruvate kinases 1 item
  137. enoyl-acyl-carrier protein reductase 1 item
  138. Rho-kinase 1 item
  139. tropomyosin receptor kinase 1 item
  140. SK 1 item
  141. PPK 1 item
  142. c-Syk 1 item
  143. CDK1/CyclinB 1 item
  144. PIM1 kinase 1 item
  145. phospholipase A2 1 item
  146. ATM 1 item
  147. PIKfyve 1 item
  148. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 286item
  2. Cell Experiments 213item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 16item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 44item
  9. Cancer 200item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 20item
  15. Colon Carcinoma 2item
  16. Colorectal Cancer 19item
  17. Diabetes 1 item
  18. Glioblastoma 17item
  19. Glioma 7item
  20. Hepatocellular Carcinoma 4item
  21. HIV Infections 1 item
  22. Immunological Diseases 1 item
  23. Inflammatory Bowel Disease 1 item
  24. Inflammatory Diseases 4item
  25. Leukemia 8item
  26. Liver Cancer 3item
  27. Lung Cancer 15item
  28. Lung Carcinoma 3item
  29. Lymphoma 9item
  30. Mantle Cell Lymphoma 1 item
  31. Melanoma 12item
  32. Multiple Myeloma 6item
  33. Myelofibrosis 1 item
  34. Myeloma 1 item
  35. Neuroblastoma 2item
  36. Non-small Cell Lung Cancer 5item
  37. Non-small Cell Lung Carcinoma 1 item
  38. Ovarian Cancer 15item
  39. Pancreatic Cancer 22item
  40. Prostate Cancer 17item
  41. Psoriasis 1 item
  42. Pulmonary Arterial Hypertension 1 item
  43. Renal Cancer 3item
  44. Renal Cell Carcinoma 5item
  45. Rheumatoid Arthritis 5item
  46. Thyroid Cancer 5item
  47. Type 2 Diabetes 3item